OZEMPIC.BOT
v2.1 · GLP-1 INDEX
OZEMPIC $968.52 ↓ 2.1%·WEGOVY $1,349.02 ↑ 0.4%·MOUNJARO $1,069.08 ↓ 1.8%·ZEPBOUND $1,086.37 → 0.0%·FDA · SHORTAGE RESOLVED · OCT 2024·NOVO NORDISK Q3 REVENUE +29%·ELI LILLY MARKET CAP $720B·COMPOUNDED SEMAGLUTIDE BAN UPDATE·OZEMPIC $968.52 ↓ 2.1%·WEGOVY $1,349.02 ↑ 0.4%·MOUNJARO $1,069.08 ↓ 1.8%·ZEPBOUND $1,086.37 → 0.0%·FDA · SHORTAGE RESOLVED · OCT 2024·NOVO NORDISK Q3 REVENUE +29%·ELI LILLY MARKET CAP $720B·COMPOUNDED SEMAGLUTIDE BAN UPDATE·
§ 07

Telehealth

Eight providers operating across the U.S. that can evaluate, prescribe, and ship GLP-1 medications.

⌗ How we rank

Providers are evaluated on transparency of pricing, breadth of GLP-1 formulary, state coverage, accreditation of prescribing clinicians, and verified user reviews. We do not accept payment from listed providers.